Trial intelligence / Profile preview

Dezocine Combined With Sufentanil for Postoperative Recovery in Thoracic Surgery

NCT06439368Phase 4Recruiting

Sponsor
Yangtze River Pharmaceutical Group
Start
Jan 2023
Primary completion
Dec 2024
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of dezocine in postoperative pain, sponsored by Yangtze River Pharmaceutical Group. Started Jan 2023; status: recruiting.

02

Drugs

dezocine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT06439368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06439368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call